In 1995 Dr. Blum retired from the University of Texas Health Science Center giving up tenure to enter the world of business and biotechnology. In the second year, acting as manager of 1899 Limited Liability Corporation, his first weight management product grossed in excess of 60 million retail. His company Cyberpharm has launched a weight loss system with Rexall/Showcase which was launched early 1999. Dr. Blum continues to publish research articles, writes books (twelve), lectures, and is actively applying for numerous patents in the field of molecular genetics & nutrition. Dr. Blum is very active as Scientific Director of the Path Medical Foundation and former co-founder and Vice President of the American College of Addictionology and Compulsive Disorders. Dr. Blum is co-founder and Chairman & CSO of LifeGen. His concept of Reward Deficiency Syndrome is being embraced by world leaders in science and the DRD2 gene discovery has been confirmed in over 3,000 publications from laboratories all over the world. He serves as Editor –in-Chief Omics Journal of Genetic
Syndromes & Gene Therapy and is currently serving on ten other prestigious journal's editorial Boards. Currently he has been named Volunteer Full Professor of the Department of Psychiatry & McKnight Brain Institute University of Florida College of Medicine, Gainesville, Florida and Adjunct Research Professor, Global Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT. He currently serves as neuroscience advisor for Dominion Diagnostics, LLC North Kingstown Rhode Island; G & G Holistic Addiction Treatment center, North Miami Beach Florida and Malibu Beach Recovery Center, Malibu Beach, California. Many consider him as the “Father of Psychiatric Genetics” and “Father of Neuro Nutrient Therapy”. Dr. Blum received the Life Time Achievement Award from the National Institute of Holistic Addiction Studies 2011 and Best Abstract Award from the American Society of Anesthesiology and Pain. He is currently in discussions with Oxford University Press concerning a book on “Reward Deficiency Syndrome” and Springer is considering him along with Mark Gold as Series editor for Neuroscience of Addiction books.